Credit Suisse Downgrades Lumenis After Takeout Offer

In a report published Friday, Credit Suisse analyst Bruce Nudell downgraded the rating on Lumenis Ltd. LMNS from Outperform to Underperform, with a price target of $14, following the announcement that the approval of the sale of the company. The analyst believes that Lumenis is likely to have exhausted all options for a more attractive offer before approving the takeout bid by XIO Group, although the company has not share information regarding the transaction negotiations. A higher bid is unlikely to come forth for Lumenis. "We expect LMNS to continue to execute on its high-single digit sales growth trajectory & do not anticipate meaningful risk to consummation of the announced transaction but we now believe the stock has a less attractive return profile than the rest of our sector," the Credit Suisse report said. The company is to be acquired for $14 per share. The deal is likely to be closed by September 2015.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorDowngradesAnalyst RatingsCredit Suisse
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!